events
News and Community
Content by Category
Artificial Intelligence in Health Tech
Medical Cloud Computing
Patient Engagement
EHR/EMR
Telehealth
Our Network
IT Tech News
CXO Insiders
Rev Tech News
Fin Tech News
HR Tech News
Client Papers
Soc News
Martech-News
events
News and Community
Content by Category
Artificial Intelligence in Health Tech
Medical Cloud Computing
Patient Engagement
EHR/EMR
Telehealth
Our Network
IT Tech News
CXO Insiders
Rev Tech News
Fin Tech News
HR Tech News
Client Papers
Soc News
Martech-News
Search
Login
events
News and Community
Content by Category
Artificial Intelligence in Health Tech
Medical Cloud Computing
Patient Engagement
EHR/EMR
Telehealth
Our Network
IT Tech News
CXO Insiders
Rev Tech News
Fin Tech News
HR Tech News
Client Papers
Soc News
Martech-News
events
News and Community
Content by Category
Artificial Intelligence in Health Tech
Medical Cloud Computing
Patient Engagement
EHR/EMR
Telehealth
Our Network
IT Tech News
CXO Insiders
Rev Tech News
Fin Tech News
HR Tech News
Client Papers
Soc News
Martech-News
Login
News and Community
Biopharmaceutical Innovation
,
Cardiac Gene Therapy
,
Clinical Trials
,
Drug Discovery
,
Fda Fast Track
,
Gene Therapy Platforms
,
Healthcare Technology
,
Human-based Drug Discovery
,
Iqvia
,
Medera
August 5, 2026
IQVIA and Medera Partner to Advance Cardiac Gene Therapy and Drug Discovery
Biopharmaceutical Innovation
,
Blood-brain Barrier Therapy
,
Enzyme Replacement Therapy
,
Genetic Disease Therapy
,
Healthcare Technology
,
Hunter Syndrome Treatment
,
Izcargo Therapy
,
Jcr Pharmaceuticals
,
Pharmaceutical Approval
,
Rare Disease Medicine
,
Rare Disease Treatment
July 22, 2026
JCR Pharmaceuticals Secures UAE Marketing Authorization for IZCARGO™, a Blood-Brain Barrier-Penetrating Therapy for Hunter Syndrome
Biopharma Industry
,
Biopharmaceutical Innovation
,
Edison Scientific
,
Incyte
,
Kosmos Ai Platform
,
Translational Biology
May 20, 2026
Incyte and Edison Scientific Announce Partnership to Employ Kosmos AI Platform for Research and Development
Biopharmaceutical Innovation
,
Drug Delivery
,
Epis Nexlab
,
Long-acting Semaglutide
,
Microsphere Technology
,
Samsung Bioepis
March 16, 2026
Samsung Bioepis and Epis NexLab Partner with G2GBIO to Develop Long-Acting Semaglutide
Load More